Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
HSIC logo

Henry Schein Posts 5.2% Sales Growth and 7.7% EPS Rise in Resilient Quarter

HSIC10-QFiling Date: 11/4/2025
Henry Schein, Inc.
Description

What this story covers

Henry Schein reported Q3 net sales of $3.339B, up 5.2%, with EPS at $0.84, up 7.7%. Growth driven by internal momentum amid margin pressures; strategic One Schein initiative and KKR investment bolster outlook. Liquidity strong at $1.246B working capital; no major risk changes.

Story snapshot

CompanyHenry Schein, Inc.
TickerHSIC
VariantStandard detailed
Duration15:35
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001000228-25-000066

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in